Edition:
United Kingdom

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

15.00USD
23 Feb 2018
Change (% chg)

$-0.02 (-0.13%)
Prev Close
$15.02
Open
$15.00
Day's High
$15.45
Day's Low
$14.80
Volume
10,376
Avg. Vol
--
52-wk High
$16.10
52-wk Low
$11.10

Chart for

About

Cue Biopharma Inc is a United States-based development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Peter Appel Reports Passive Stake Of 7.6 Pct In Cue Biopharma

* PETER APPEL REPORTS A PASSIVE STAKE OF 7.6 PERCENT IN CUE BIOPHARMA INC AS OF DEC 27, 2017 - SEC FILING Source text: (http://bit.ly/2BWquxU) Further company coverage:

13 Feb 2018

BRIEF-Mark Strome Reports 5.7 Pct Passive Stake In Cue Biopharma

* MARK STROME REPORTS A 5.7 PERCENT PASSIVE STAKE IN CUE BIOPHARMA INC AS OF DECEMBER 27, 2017- SEC FILING Source: (http://bit.ly/2AIDG48) Further company coverage:

09 Jan 2018

BRIEF-Cue Biopharma sees IPO of up to 8 mln shares of its common stock priced at $7.50/shr

* CUE BIOPHARMA INC SEES IPO OF UP TO 8 MILLION SHARES OF ITS COMMON STOCK PRICED AT $7.50 PER SHARE - SEC FILING

05 Dec 2017

Earnings vs. Estimates

No consensus analysis data available.